| Income Statement | 2024-06-30 | |||
|---|---|---|---|---|
| Total revenue | 433,982 | |||
| General and administrative expenses | 36,738 | |||
| Transaction expenses | 664 | |||
| Cost of revenue | 404,589 | |||
| Total costs and expenses | 441,991 | |||
| Loss from operations | -8,009 | |||
| Other (expense) income, net | 5,547 | |||
| Interest income | 1,025 | |||
| Interest expense | 1,833 | |||
| Loss before income taxes, equity loss in affiliate, and noncontrolling interest | -3,270 | |||
| Income tax expense (benefit) | -324 | |||
| Loss before equity loss in affiliate and noncontrolling interest | -2,946 | |||
| Equity in loss of affiliate | -179 | |||
| Net loss before noncontrolling interest | -3,125 | |||
| Net loss attributable to redeemable noncontrolling interest | -6,412 | |||
| Net loss attributable to noncontrolling interest | -334 | |||
| Net loss attributable to class a common stockholders, basic | 3,621 | |||
| Net loss attributable to class a common stockholders, diluted | 3,621 | |||
| Basic eps | 120 | |||
| Diluted eps | -110 | |||
| Basic average shares | 11,377,407 | |||
| Diluted average shares | 37,089,605 | |||
American Oncology Network, Inc. (AONC)
American Oncology Network, Inc. (AONC)